{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T07:47:32Z","timestamp":1791100052203,"version":"4.1.0"},"reference-count":24,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Scandinavian Journal of Rheumatology"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.3109\/03009742.2013.824023","type":"journal-article","created":{"date-parts":[[2013,10,18]],"date-time":"2013-10-18T04:49:06Z","timestamp":1382071746000},"page":"162-169","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":39,"title":["Interleukin-18 as an efficient marker for remission and follow-up in patients with inactive adult-onset Still\u2019s disease"],"prefix":"10.3109","volume":"43","author":[{"given":"K-H","family":"Jung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-J","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-S","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T-H","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-B","family":"Jun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DH","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2013,10,18]]},"reference":[{"key":"CIT0001","first-page":"564","volume":"65","author":"Efthimiou P","year":"2006","journal-title":"Diagnosis and management of adult onset Still\u2019s disease."},{"key":"CIT0002","first-page":"773","volume":"22","author":"Adult-onset Fautrel B.","year":"2008","journal-title":"Still disease."},{"key":"CIT0003","first-page":"2189","volume":"31","author":"Chen DY","year":"2004","journal-title":"Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still\u2019s disease."},{"key":"CIT0004","first-page":"213","volume":"73","author":"Gracie JA","year":"2003","journal-title":"Interleukin-18."},{"key":"CIT0005","first-page":"224","volume":"17","author":"Boraschi D","year":"2006","journal-title":"IL-18 in autoimmunity: review."},{"key":"CIT0006","first-page":"550","volume":"44","author":"Kawashima M","year":"2001","journal-title":"Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still\u2019s disease."},{"key":"CIT0007","first-page":"1716","volume":"44","author":"Kawaguchi Y","year":"2001","journal-title":"Interleukin-18 as a novel diagnostic marker and indicator of disease severity in adult-onset Still\u2019s disease."},{"key":"CIT0008","first-page":"127","volume":"10","author":"Novick D","year":"1999","journal-title":"Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response."},{"key":"CIT0009","first-page":"16957","volume":"99","author":"Hurgin V","year":"2002","journal-title":"The promoter of IL-18 binding protein: activation by an IFN-gamma-induced complex of IFN regulatory factor 1 and CCAAT\/enhancer binding protein beta."},{"key":"CIT0010","first-page":"334","volume":"14","author":"Novick D","year":"2001","journal-title":"A novel IL-18BP ELISA shows elevated serum IL-18BP in sepsis and extensive decrease of free IL-18."},{"key":"CIT0011","first-page":"3483","volume":"106","author":"Mazodier K","year":"2005","journal-title":"Severe imbalance of IL-18\/IL-18BP in patients with secondary hemophagocytic syndrome."},{"key":"CIT0012","first-page":"121","volume":"34","author":"Novick D","year":"2010","journal-title":"High circulating levels of free interleukin-18 in patients with active SLE in the presence of elevated levels of interleukin-18 binding protein."},{"key":"CIT0013","first-page":"608","volume":"201","author":"Ianello A","year":"2010","journal-title":"HIV-1 causes an imbalance in the production of interleukin-18 and its natural antagonist in HIV-infected individuals: implications for enhanced viral replication."},{"key":"CIT0014","first-page":"424","volume":"19","author":"Yamaguchi M","year":"1992","journal-title":"Preliminary criteria for classification of adult Still\u2019s disease."},{"key":"CIT0015","first-page":"315","volume":"31","author":"Arnett FC","year":"1988","journal-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis."},{"key":"CIT0016","first-page":"361","volume":"27","author":"van der Linden S","year":"1984","journal-title":"Evaluation of diagnostic criteria for ankylosing spondylitis."},{"key":"CIT0017","first-page":"118","volume":"70","author":"Pouchot J","year":"1991","journal-title":"Adult Still\u2019s disease: manifestations, disease course, and outcome in 62 patients. Medicine (Baltimore)"},{"key":"CIT0018","first-page":"1190","volume":"97","author":"Kim SH","year":"2000","journal-title":"Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18."},{"key":"CIT0019","first-page":"73","volume":"22","author":"Shimizu C","year":"2012","journal-title":"High circulating levels of interleukin-18 binding protein indicate the severity of glomerular involvement in systemic lupus erythematosus."},{"key":"CIT0020","first-page":"322","volume":"28","author":"Fautrel B","year":"2000","journal-title":"Diagnostic value of ferritin and glycosylated ferritin in adult onset Still\u2019s disease."},{"key":"CIT0021","first-page":"287","volume":"58","author":"Shimizu M","year":"2012","journal-title":"Tocilizumab masks the clinical symptoms of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome: the diagnostic significance of interleukin-18 and interleukin-6."},{"key":"CIT0022","first-page":"1757","volume":"50","author":"Yoshida Y","year":"2011","journal-title":"Tocilizumab improved both clinical and laboratory manifestations except for interleukin-18 in a case of multiple drug-resistant adult-onset Still\u2019s disease."},{"key":"CIT0023","first-page":"449","volume":"51","author":"Nagashima T","year":"2012","journal-title":"Interleukin-18 in adult-onset Still\u2019s disease: treatment target or disease activity indicator?"},{"key":"CIT0024","first-page":"1029","volume":"37","author":"Jung SY","year":"2010","journal-title":"Serum calprotectin as a marker for disease activity and severity in adult-onset Still\u2019s disease."}],"container-title":["Scandinavian Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/03009742.2013.824023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,12,17]],"date-time":"2016-12-17T16:45:58Z","timestamp":1481993158000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.3109\/03009742.2013.824023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,18]]},"references-count":24,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2013,12,9]]},"published-print":{"date-parts":[[2014,3]]}},"alternative-id":["10.3109\/03009742.2013.824023"],"URL":"https:\/\/doi.org\/10.3109\/03009742.2013.824023","relation":{},"ISSN":["0300-9742","1502-7732"],"issn-type":[{"value":"0300-9742","type":"print"},{"value":"1502-7732","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,18]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=irhe20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=irhe20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"}]}}